Clinical Trial CTSUBRENB-43-M
Title
A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
Principal Investigator(s)
John Murray
Details
- Protocol No. CTSUBRENB-43-M
- Open Date: 04/26/2012
- Staging: Phase III
- Age Group: Adults
- Scope: National
- Objective:
- Disease Sites: Breast
- Therapies: Molecular Targeted Agents / Immunotherapy / Biologics; Radiotherapy
- Drugs: None Specified
- Participating Institutions: Meharry Medical College
- Secondary Protocol No: b-43
Description
None Provided.
Eligibility
Not provided. Please call for more information.
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
